interferoninduc
ubiquitinlik
protein
ubl
antivir
properti
core
el
enzym
conjug
human
induc
transcript
level
type
interferon
signal
sever
proteom
studi
togeth
identifi
cellular
protein
target
target
includ
broad
rang
constitut
express
protein
approxim
interferoninduc
protein
chapter
provid
overview
target
identif
process
valid
target
also
discuss
limit
number
exampl
biochem
effect
conjug
target
protein
character
innat
immun
respons
mammalian
cell
firstlin
defens
viral
microbi
infect
system
nonspecif
respect
antigen
recognit
instead
gear
recogn
class
molecul
commonli
produc
microb
virus
lipopolysaccharid
flagellin
doublestrand
rna
molecul
refer
pamp
pattern
associ
molecular
pattern
pathogen
recognit
receptor
prr
tolllik
receptor
rigi
doublestrand
rnaactiv
protein
kinas
pkr
directli
recogn
pamp
trigger
signal
pathway
lead
product
type
interferon
ifn
two
major
form
type
ifn
produc
primarili
leukocyt
produc
wide
rang
cell
type
includ
fibroblast
epitheli
cell
type
ifn
secret
infect
cell
bind
interferon
receptor
ifnar
surround
cell
well
initi
infect
cell
result
transcript
hundr
interferon
stimul
gene
isg
express
isg
lead
gener
multifacet
defens
system
serv
limit
viral
microbi
infect
isg
denot
approxim
molecular
mass
protein
although
actual
molecular
mass
matur
form
protein
kd
first
identifi
base
rapid
induct
ehrlich
ascit
tumor
cell
ifn
stimul
decad
later
art
haa
cowork
recogn
would
turn
first
mani
ubiquitinlik
protein
ubl
modifi
discuss
would
nearli
anoth
two
decad
shown
actual
antivir
activ
rang
virus
includ
influenza
sindbi
herp
hiv
ebola
viru
far
report
demonstr
antimicrobi
function
timelin
discoveri
span
year
shown
figur
like
ubiquitin
ub
ubl
synthes
precursor
protein
must
process
reveal
ctermin
glycin
residu
ident
process
enzym
unknown
deconjug
enzym
clearli
essenti
process
knockout
mous
still
gener
process
conjugationcompet
also
inconsist
literatur
concern
role
murin
specif
deconjug
enzym
report
activ
ubiquitin
neurolog
phenotyp
knockout
mous
also
seen
doubl
knockout
mous
indic
accumul
conjug
account
phenoytp
difficulti
identifi
specif
deisgyl
enzym
one
inde
exist
like
complic
fact
last
six
residu
ident
ubiquitin
lrlrgg
residu
must
recogn
activ
site
deconjug
enzym
consist
presum
deubiquitin
enzym
also
shown
activ
conjug
conjug
human
target
protein
occur
via
enzymat
cascad
consist
singl
enzym
enzym
singl
major
enzym
gene
encod
protein
transcript
induc
although
induct
delay
rel
therefor
free
unconjug
rapidli
induc
interferon
stimul
conjug
occur
appreci
degre
approxim
hour
stimul
understood
delay
built
conjug
system
although
rule
free
function
independ
conjug
enzym
monomer
enzym
unlik
heterodimer
enzym
sumo
enzym
report
ubiquitin
determin
kinet
constant
ub
indic
unlik
function
ubiquitin
vivo
major
human
cell
hect
domain
ligas
ntermin
repeat
deplet
lead
dramat
decreas
overal
conjug
activ
affect
conjug
vast
major
cellular
target
protein
addit
protein
may
requir
conjug
form
core
ifninduc
compon
system
coexpress
reconstitut
robust
conjug
nonifnstimul
cell
isgyl
target
protein
far
reconstitut
vitro
difficulti
appear
lay
level
enzym
biochem
activ
vitro
interestingli
human
direct
equival
mice
rat
howev
human
gene
adjac
chromosom
clearli
relat
gene
duplic
event
gene
transcript
regul
interferon
signal
human
protein
ident
similar
domain
organ
mous
interferoninduc
locat
correspond
genom
posit
human
propos
result
gene
duplic
primat
lineag
like
incorrect
sinc
mammal
dog
cow
sheep
gene
similar
arrang
human
genom
suggest
lost
evolut
rodent
lineag
although
evid
human
play
signific
role
conjug
conceiv
murin
play
equival
role
human
conjug
murin
knowledg
possibl
yet
experiment
test
support
antivir
function
first
report
found
influenza
b
viru
block
conjug
cellular
protein
sinc
report
antivir
effect
influenza
sindbi
vaccinia
vacv
herp
simplex
murin
ebola
viru
recent
studi
mice
lack
highlight
import
conjug
mice
infect
either
sindbi
influenza
b
viru
produc
free
conjug
shown
increas
suscept
virus
addit
influenza
b
virus
also
evolv
mechan
interf
conjug
sar
coronaviru
encod
proteas
deconjug
target
protein
vaccinia
viru
encod
viral
earli
protein
bind
prevent
isgyl
importantli
precis
biochem
function
biochem
basi
antivir
activ
remain
unknown
order
understand
mechan
conjug
contribut
antivir
respons
import
identifi
protein
target
pathway
describ
proteom
studi
identifi
cellular
target
function
consequ
isgyl
also
discuss
although
determin
small
number
target
protein
isgyl
target
protein
detect
two
cellbas
method
either
treatment
interferonrespons
cell
eg
hela
purifi
cotransfect
noninterferonstimul
cell
four
plasmid
express
core
conjug
compon
hela
cell
conjug
detect
approxim
hour
treatment
maxim
accumul
conjug
hour
posttreat
cotransfect
experi
cell
transfect
plasmid
express
tag
untag
case
extract
typic
prepar
hour
treatment
transfect
total
cellular
protein
separ
sdspage
transfer
nitrocellulos
membran
membran
probe
antibodi
santa
cruz
antibodi
antiflag
antibodi
sigma
detect
conjug
often
use
use
acrylamid
gel
order
observ
free
unconjug
conjug
typic
rang
size
approxim
kd
high
molecular
weight
adduct
migrat
near
top
gel
figur
show
time
cours
conjug
follow
cotransfect
plasmid
express
note
least
hand
respond
poorli
stimul
littl
endogen
conjug
detect
cell
ubiquitin
largescal
mass
spectrometrybas
identif
target
yeast
protein
first
report
approach
involv
express
ntermin
tag
ubiquitin
molecul
affin
purif
conjug
denatur
condit
multidimension
liquid
chromatographi
coupl
tandem
mass
spectrometri
identifi
conjug
protein
basi
mass
spectrometri
identif
ubiquitin
ubl
modifi
criteria
consid
protein
target
discuss
elsewher
base
gener
principl
three
proteom
studi
perform
identifi
cellular
protein
conjug
zhao
et
al
express
doubletag
protein
flag
ntermin
tag
along
hela
cell
treat
transfect
cell
extract
prepar
hour
ifn
treatment
conjug
purifi
denatur
condit
ninta
resin
follow
purif
antiflag
bead
purif
denatur
condit
assur
conjug
protein
would
identifi
oppos
protein
associ
conjug
protein
isol
protein
separ
sdspage
region
gel
subject
trypsin
digest
peptid
separ
identifi
liquid
chromatographi
mass
spectrometri
describ
studi
identifi
approxim
highconfid
target
second
studi
giannakopol
et
al
identifi
conjug
interferontr
human
cell
cell
mous
mef
conjug
immunopurifi
use
antibodi
recogn
endogen
express
mass
spectrometri
identifi
total
mous
human
protein
immunoprecipit
final
wong
et
al
stabli
express
cell
immunopurifi
conjug
hour
treatment
target
protein
identifi
studi
togeth
three
studi
identifi
slightli
uniqu
protein
potenti
target
protein
identif
target
protein
highli
anticip
hope
would
provid
valuabl
insight
biolog
function
exampl
case
identif
target
sumo
target
identif
reveal
high
percentag
target
nuclear
protein
involv
regul
dnaand
rnarel
process
unfortun
identif
target
protein
particularli
reveal
target
larg
abund
constitut
express
protein
except
approxim
target
interferoninduc
protein
interferoninduc
target
includ
bettercharacter
antivir
isg
includ
pkr
mxa
rigi
pkr
rigi
mention
pathogen
recognit
receptor
translat
inhibitor
mxa
endoplasm
reticulumassoci
gtpase
constitut
express
protein
includ
cytoplasm
nuclear
protein
involv
divers
array
cellular
function
includ
cytoskelet
organ
stress
respons
translat
transcript
rna
splice
gener
metabol
therefor
clear
predict
biolog
function
could
infer
divers
set
target
protein
final
note
common
primari
sequenc
motif
identifi
within
set
target
protein
might
serv
recognit
signal
isgyl
basi
substrat
recognit
isgyl
machineri
remain
unknown
valid
target
perform
sever
differ
way
depend
avail
antibodi
target
express
level
endogen
target
protein
degre
target
protein
modifi
simplest
case
use
induc
conjug
system
hour
follow
immunoblot
endogen
target
protein
presenc
conjug
seen
appear
modifi
form
protein
correspond
kd
ubl
multipl
conjug
kd
interv
seen
among
target
evid
repres
chain
mass
spectrometri
base
map
modif
site
individu
target
protein
strongli
suggest
repres
singl
moieti
multipl
lysin
residu
target
protein
unpublish
result
pattern
modifi
band
may
appear
complic
due
fact
monoisgyl
protein
modifi
differ
site
target
protein
may
result
slightli
differ
migrat
sdspage
gel
case
modifi
form
confirm
conjug
sirna
knockdown
one
conjug
enzym
importantli
small
number
target
protein
valid
direct
western
blot
ifntreat
cell
primarili
ifninduc
highli
express
mxa
may
primarili
due
fact
isgyl
ineffici
process
typic
robust
conjug
observ
order
total
pool
target
case
much
lower
altern
immunoprecipit
target
protein
follow
immunoblot
ipwestern
may
serv
enrich
target
protein
result
sensit
detect
conjug
conjug
also
concentr
immunoprecipit
total
conjug
immunoblot
individu
target
protein
singl
success
way
valid
isgyl
target
transient
express
target
protein
along
conjug
compon
without
nonifntr
cell
prior
identif
major
modif
target
case
valid
coexpress
target
retrospect
combin
compon
like
suffici
modif
protein
basal
level
express
conjug
detect
hela
cell
coexpress
sirna
dramat
decreas
level
conjug
coexpress
boost
level
conjug
figur
show
modif
four
epitopetag
target
protein
presenc
tripl
quadrupl
combin
conjug
compon
demonstr
modif
case
detect
basal
level
express
case
strongli
enhanc
coexpress
describ
number
cellbas
approach
use
gener
isgyl
protein
valid
modif
individu
protein
howev
import
note
vitro
isgyl
system
yet
establish
without
system
possibl
easili
gener
purifi
isgyl
target
protein
biochem
analys
key
reason
modest
progress
made
understand
biochem
function
conjug
nevertheless
small
number
studi
examin
modif
differ
target
cellular
target
protein
describ
biochem
consequ
modif
four
target
discuss
filamin
b
ubiquitin
enzym
function
gener
polyubiquitin
chain
identifi
cellular
target
isgyl
one
three
proteom
studi
discuss
two
subsequ
report
show
isgyl
lysin
residu
lie
near
activesit
cystein
residu
protein
studi
show
isgyl
form
defect
ubiquitin
thioester
format
given
proxim
structur
inhibit
thioester
format
like
simpli
result
steric
occlus
conjug
molecul
downstream
effect
inhibit
suggest
result
prevent
nfkb
activ
polyubiquitin
catalyz
complex
critic
compon
signal
pathway
lead
nfkb
activ
nfkb
activ
turn
critic
transcript
activ
gene
involv
innat
immun
respons
includ
unresolv
problem
propos
mechan
small
fraction
isgyl
clear
would
lead
signific
inhibit
overal
activ
filamin
b
one
three
relat
actin
bind
protein
critic
crosslink
cortic
actin
filament
identifi
one
three
largescal
proteom
project
discuss
earli
time
point
interferon
stimul
filamin
b
tether
map
kinas
modul
promot
activ
jnk
jnkmediat
apopotosi
isgyl
filamin
b
shown
lead
releas
scaffold
prevent
jnk
activ
model
propos
wherebi
isgyl
filamin
b
rel
late
time
point
interferon
stimul
lead
inactiv
jnk
protein
phosphatas
identifi
two
proteom
studi
dephosphoryl
ikk
kinas
lead
inhibit
nfkb
signal
shown
isgyl
inhibit
activ
final
case
isgyl
activ
rather
inactiv
target
protein
mrna
cap
bind
protein
report
increas
cap
bind
activ
follow
isgyl
biochem
basi
enhanc
bind
unknown
clearer
pictur
emerg
enzym
requir
isgyl
ident
cellular
target
isgyl
spectrum
virus
sensit
antivir
effect
isgyl
major
gap
understand
concern
basi
enzymesubstr
recognit
conjug
process
singl
major
enzym
target
cellular
protein
isgyl
known
target
directli
relat
antivir
activ
precis
biochem
effect
target
protein
establish
vitro
isgyl
system
import
address
problem
better
understand
precis
step
inhibit
cours
life
cycl
relev
virus
timecours
total
conjug
noninterferontr
cell
cell
transfect
plasmid
express
cell
extract
collect
indic
time
point
analyz
immunoblot
antiflag
antibodi
durfe
